Pharmalittle: FDA panel nixed Duchenne drug, Hims & Hers sued| STAT
Top of the morning to you, and a fine one it is. Skies are gray but rain is…
Peptides are rising in popularity, but health experts warn ‘very few of them’ have any benefits – CTV News
Peptides are rising in popularity, but health experts warn ‘very few of them’ have any benefits CTV NewsPeptides are…
I jumped at the chance to try the Wegovy pill instead of fat jabs
When the Wegovy pills were launched in the U.S., there was no doubt in Rachael’s mind that this…
Levothyroxine: Thyroid medication recalled across US due to low potency – The Independent
Levothyroxine: Thyroid medication recalled across US due to low potency The IndependentFDA Issues Nationwide Recall of Thyroid Medication Due…
Thousands of patients to benefit from new daily pill for serious heart condition following co-ordinated MHRA and NICE decisions
Around 6,600 people in England with a serious heart condition will be able to access a new treatment…
Peptides are the latest trend in the wellness industry. Experts warn the hype outpaces the research – CTV News
Peptides are the latest trend in the wellness industry. Experts warn the hype outpaces the research CTV NewsPeptides are…
‘Blood everywhere’ – Lindsay Clancy’s ex-husband testifies in murder trial
Warning: This story contains distressing details and discussion of attempted suicide Patrick Clancy, the ex-husband of the Massachusetts…
Loving your body in a world where weight stigma helps sell GLP-1 drugs
Whether you’re living in a body that’s large or small, the rise of GLP-1 advertising and its use…
Oral Ozempic Cuts Heavy Drinking and Cravings
Summary: In a clinical trial, oral semaglutide was found to significantly reduce heavy drinking days, daily cravings, and…
New, more efficient pill to lower cholesterol
The United States Food and Drug Administration (FDA) last Thursday approved a new daily pill that lowers levels…
Brazil approves generic GLP-1 drug sold by Swiss firm Sandoz
Brazil, Canada and India are some of the first countries where the patents to GLP-1 drugs expire. Keystone-SDA…
Utah joins lawsuit against Hims & Hers telehealth company
SALT LAKE CITY — Utah’s Division of Consumer Protection has joined a lawsuit against telehealth company Hims &…